Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

If congestion, postnasal drip, or sinus pressure consistently follows an Ozempic injection, there may be a link. However, if symptoms vary or occur independently of the medication schedule ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

While Ozempic and similar drugs have become highly in demand for weight loss, one holistic doctor has shared three foods that she says can be just as effective. Dr. Taz Bhatia, a board-certified ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...